Clinical Trial Update: Antiviral Activity of AZD7295 in HCV Carriers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating antiviral activity of AZD7295 in Hepatitis C carriers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• AZD7295 (AZD7295)

Snippet

Sponsor: Arrow Therapeutics | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED